Biopol Chemicals Ltd

Biopol Chemicals Ltd

₹ 126 -1.72%
18 May 3:40 p.m.
About

Incorporated in 2023, Biopol Chemicals Limited is engaged in the manufacturing and distribution of specialty chemicals categorized into silicones, emulsifiers, biochemicals, and polyelectrolytes.[1]

Key Points

Business Profile[1]
Biopol Chemicals Limited is engaged in the manufacturing, trading and distribution of specialty chemicals. The company operates on a B2B model, supplying to institutional and industrial customers. Its offerings cater primarily to textiles, home care, agriculture and industrial chemical applications. Alongside products, the company also provides technical consultancy services related to chemical applications and formulations.

  • Market Cap 136 Cr.
  • Current Price 126
  • High / Low 134 / 84.8
  • Stock P/E 15.2
  • Book Value 46.2
  • Dividend Yield 0.00 %
  • ROCE 34.1 %
  • ROE 28.3 %
  • Face Value 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 31.1%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2025 Sep 2025 Mar 2026
33.85 31.66 49.49
29.39 27.25 40.46
Operating Profit 4.46 4.41 9.03
OPM % 13.18% 13.93% 18.25%
0.00 0.10 0.13
Interest 0.38 0.53 0.99
Depreciation 0.04 0.04 0.06
Profit before tax 4.04 3.94 8.11
Tax % 25.74% 25.63% 25.52%
3.00 2.93 6.04
EPS in Rs 3.79 3.70 5.59
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2024 Mar 2025 Mar 2026
25.42 49.13 81.14
20.99 42.59 67.69
Operating Profit 4.43 6.54 13.45
OPM % 17.43% 13.31% 16.58%
0.00 0.02 0.23
Interest 0.39 0.68 1.52
Depreciation 0.08 0.07 0.10
Profit before tax 3.96 5.81 12.06
Tax % 25.25% 25.13% 25.62%
2.96 4.34 8.97
EPS in Rs 3.74 5.49 8.30
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 65%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 107%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 31%
Last Year: 28%

Balance Sheet

Figures in Rs. Crores

Mar 2024 Mar 2025 Mar 2026
Equity Capital 7.91 7.91 10.81
Reserves 1.29 5.63 39.12
3.58 7.68 8.47
4.77 10.26 11.38
Total Liabilities 17.55 31.48 69.78
0.21 0.23 14.24
CWIP 0.06 0.00 0.12
Investments 0.00 0.00 0.00
17.28 31.25 55.42
Total Assets 17.55 31.48 69.78

Cash Flows

Figures in Rs. Crores

Mar 2024 Mar 2025 Mar 2026
-6.44 -2.34 -12.77
-0.64 -0.02 -14.53
7.14 3.43 26.67
Net Cash Flow 0.06 1.07 -0.63
Free Cash Flow -6.53 -2.36 -26.97
CFO/OP -141% -28% -93%

Ratios

Figures in Rs. Crores

Mar 2024 Mar 2025 Mar 2026
Debtor Days 145.45 123.77 125.01
Inventory Days 121.21 107.04 113.43
Days Payable 77.90 77.77 37.25
Cash Conversion Cycle 188.76 153.05 201.19
Working Capital Days 127.36 95.17 178.90
ROCE % 38.18% 34.12%

Shareholding Pattern

Numbers in percentages

21 Recently
Mar 2026
65.81%
9.30%
2.92%
21.98%
No. of Shareholders 228

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents